BRAINCOOL AB (5YL) - Total Liabilities
Based on the latest financial reports, BRAINCOOL AB (5YL) has total liabilities worth €16.58 Million EUR (≈ $19.38 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BRAINCOOL AB (5YL) net asset momentum to track the company's year-over-year net asset growth rate.
BRAINCOOL AB - Total Liabilities Trend (2021–2025)
This chart illustrates how BRAINCOOL AB's total liabilities have evolved over time, based on quarterly financial data.
BRAINCOOL AB Competitors by Total Liabilities
The table below lists competitors of BRAINCOOL AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NanoViricides Inc
NYSE MKT:NNVC
|
USA | $1.18 Million |
|
Caravelle International Group
NASDAQ:HTCO
|
USA | $19.76 Million |
|
Zodiac Clothing Company Limited
NSE:ZODIACLOTH
|
India | Rs1.63 Billion |
|
Agat Ejendomme A/S
CO:AGAT
|
Denmark | Dkr502.00 Million |
|
Ecocab Co. Ltd
KQ:128540
|
Korea | ₩58.36 Billion |
|
Allied Industrial Ltd
TWO:4702
|
Taiwan | NT$218.53 Million |
|
Z-Com Inc
TWO:8176
|
Taiwan | NT$150.51 Million |
|
Dorsavi Ltd
AU:DVL
|
Australia | AU$1.14 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down BRAINCOOL AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 5YL market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BRAINCOOL AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BRAINCOOL AB (2021–2025)
The table below shows the annual total liabilities of BRAINCOOL AB from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €16.58 Million ≈ $19.38 Million |
+2.90% |
| 2024-12-31 | €16.11 Million ≈ $18.83 Million |
-25.22% |
| 2023-12-31 | €21.54 Million ≈ $25.18 Million |
+23.53% |
| 2022-12-31 | €17.44 Million ≈ $20.39 Million |
-67.78% |
| 2021-12-31 | €54.12 Million ≈ $63.28 Million |
-- |
About BRAINCOOL AB
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powe… Read more